Half Year Update

BioVentix PLC – BVXP – Half-year Report

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces its unaudited interim results for the six-month...

Read More